A panel of 4 clinicians with experience in pediatric pulmonology discuss current research findings and gaps in studies of pediatric obstructive sleep apnea, particularly regarding cardiovascular risk.
In patients with COPD, sleep parameters were not significantly improved after completion of a pulmonary rehabilitation program.
Objective short sleep duration is associated with daytime sleepiness, whereas obstructive sleep apnea is associated with obesity, dyslipidemia, and hypertension.
In obese patients with OSA, higher weight reduction was achieved in those who participated in a calorie restricted weight loss program and who received CPAP treatment.
Patients with type 2 diabetes are at increased risk of developing obstructive sleep apnea, independent of other factors.
The FDA has approved Sunosi to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or OSA.
Adolescent athletes have an increased prevalence of sleep disordered breathing.
Sleep apnea severity was associated with elevated pulmonary capillary wedge pressure in adults.
Investigators evaluated the characteristics of obstructive sleep apnea symptom subtypes and examined their relationship with prevalent and incident cardiovascular disease in the Sleep Heart Health Study.
The procedure, known as Elevoplasty, was investigated in the S.I.L.E.N.C.E. study (Snoring Intervention via Elevoplasty in a Non-surgical Clinical Environment) which included 52 patients.
